Jing Ying Ma from San Diego, CA, age 66

Lawyers & Attorneys

Jing Ma - Lawyer

view source

Specialties:

Commercial Transactions
Mergers and Acquisitions
Securities
Corporate Law
Arbitration
Litigation

ISLN:

918685122

Admitted:

2005

University:

Peking University, Beijing, China, B.A., 1996; Peking University, Beijing, China, B.A., 1996; Peking University, Beijing, China, M.A., 1999; Peking University, Beijing, China, M.A., 1999

Law School:

Boston University, J.D., 2004

Name / Title

Company / Classification

Phones & Addresses

Jing Guang Ma
President

MAZH INC
Nonclassifiable Establishments

252 S Western Ave, Los Angeles, CA 90004

Jing Ma
President

CELVAX, INC
Business Services at Non-Commercial Site · Nonclassifiable Establishments

12886 Ralston Cir, San Diego, CA 92130

Jing Ma

Rich Industry LLC

22826 Lazy Trl Rd, Pomona, CA 91765

Jing Ma
President

America Sepiolite Ore Fiber Products, Inc
Import and Export Ore Fiber Machine

4812 Del Amo Blvd, Torrance, CA 90503
310 370-7218

Jing Ma
President

AMERICA SEPIOLITE ORE AND FIBER PRODUCTS, INC

1011 S Fremont Ave, Alhambra, CA 91803

Jing Ma
President

LIMA TRADING, INC

18760 E Amar Rd STE 229, Walnut, CA 91789

Jing Ma
Director, President, Secretary, Treasurer

Bay Area Labs, Inc

34313 Gadwall Cmn, Fremont, CA 94555

Us Patents

System For Operating A Programmable Logic Device Having A Defective Region
view source
US Patent:

7228521, Jun 5, 2007
Filed:

Feb 1, 2005
Appl. No.:

11/048333
Inventors:

Jing Hua Ma - San Jose CA, US
Benhai Zhang - San Jose CA, US
Assignee:

XILINX Inc. - San Jose CA
International Classification:

G06F 17/50
H03K 19/00
US Classification:

716 17, 716 12, 716 14
Abstract:

A code is generated for a programmable logic device (“PLD”) having a plurality of regions including at least one defective region. The code indicates a defective region or regions of the PLD. A user enters the code before running placement and routing. A guide file associated with the code blocks out the defective region(s) of the PLD during placement and routing.

Methods For Improvement Of Lung Function Using Tgf-Beta Inhibitors
view source
US Patent:

20040146509, Jul 29, 2004
Filed:

Jul 23, 2003
Appl. No.:

10/626004
Inventors:

Zhihe Li - Foster City CA, US
David Liu - Palo Alto CA, US
Jing Ma - Cupertino CA, US
Andrew Protter - Palo Alto CA, US
George Schreiner - Los Altos CA, US
International Classification:

A61K039/395
US Classification:

424/144100
Abstract:

The invention concerns methods for improvement of lung function by administering non-peptide small molecule inhibitors of TGF- specifically binding to the type I TGF- receptor (TGF-R1). Preferably, the inhibitors are quinazoline derivatives.

Preparation And Application Of Anti-Tumor Bifunctional Fusion Proteins
view source
US Patent:

20040254108, Dec 16, 2004
Filed:

Nov 26, 2003
Appl. No.:

10/723003
Inventors:

Jing Ma - San Diego CA, US
Yajun Guo - Shanghai, CN
International Classification:

A61K038/17
C07K014/705
US Classification:

514/012000, 530/350000, 536/023500, 435/069700, 435/320100, 435/325000
Abstract:

Provided herein is a chimeric protein, which chimeric protein comprises a Flt3 ligand, or a biologically active fragment thereof, and a proteinuous or peptidyl tumoricidal agent, and uses thereof, particularly in the treatment of malignancy.

Antibodies Specific For Cancer Associated Antigen Sm5-1 And Uses Thereof
view source
US Patent:

20050031617, Feb 10, 2005
Filed:

Nov 26, 2003
Appl. No.:

10/722849
Inventors:

Jing Ma - San Diego CA, US
Yajun Guo - Shanghai, CN
International Classification:

A61K039/395
C07K016/40
US Classification:

424146100, 530388260
Abstract:

The invention concerns antibodies which is specific for SM5-1 antigen expressed in melanoma, breast cancer and hepatocellular carcinoma, and polynucleotides encoding the antibodies. The invention further concerns use of such antibodies and/or polynucleotides in diagnosing and treating malignancies.